At an R&D Day meeting today for the investment community, AbbVie Inc (NYSE:ABBV), a global biopharmaceutical company, will present an overview of its innovative …
AbbVie Inc (NYSE:ABBV) announced financial results for the first quarter ended March 31, 2016. “AbbVie delivered strong first-quarter results, including significant revenue and EPS …
AbbVie Inc (NYSE:ABBV) announced financial results for the fourth quarter and full year ended Dec. 31, 2015.
AbbVie Inc (NYSE:ABBV) is an interesting business – it has the highest qualitative risk of any Dividend Aristocrat. Risk and Dividend Aristocrats typically …
Evercore ISI analyst Mark Schoenebaum weighed in today with his views on AbbVie Inc (NYSE:ABBV), as the company is scheduled to report its second-quarter earnings results on Friday, …
